Transforming Cardiovascular Risk Management with PCSK9 Inhibitors PCSK9 Inhibitors: Transforming Lipid Management and Cardiovascular Health The global landscape of cardiovascular therapeutics has witnessed a significant transformation with the advent of PCSK9 inhibitors, a revolutionary class of drugs that have redefined the management of hypercholesterolemia and cardiovascular risk. PCSK9...